| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.49 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.005 |